(Q34235050)

25214238

31 July 2017

title

Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death (English)

1 reference

31 July 2017

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214238%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Donna Rowen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214238%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Maximilian Lebmeier

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214238%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Anthony J Hatswell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214238%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Louisa Pericleous

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214238%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Dawn Lee

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214238%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

10 September 2014

1 reference

25214238

Health and Quality of Life Outcomes

31 July 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214238%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214238%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214238%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

1 June 2020

copyright license

start time

10 September 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4173059

Estimating QALY gains in applied studies: a review of cost-utility analyses published in 2010.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4173059

Utility elicitation study in the UK general public for late-stage chronic lymphocytic leukaemia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4173059

Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4173059

Deriving a preference-based measure for cancer using the EORTC QLQ-C30

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4173059

A longitudinal comparison of 5 preference-weighted health state classification systems in persons with intervertebral disk herniation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4173059

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4173059

Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4173059

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4173059

Societal preference values for advanced melanoma health states in the United Kingdom and Australia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4173059

Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4173059

The prognostic significance of patient-reported outcomes in cancer clinical trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4173059

Health utilities using the EQ-5D in studies of cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4173059

Modelling SF-6D health state preference data using a nonparametric Bayesian method

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4173059

Health state utilities for metastatic breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4173059

Quality of life and cost-effectiveness of interferon-alpha in malignant melanoma: results from randomised trial.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4173059

The estimation of a preference-based measure of health from the SF-36.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4173059

Quality-adjusted life expectancies in patients with rheumatoid arthritis--comparison of index scores from EQ-5D, 15D, and SF-6D.

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12955-014-0140-1

Estimating the relationship between preference-based generic utility instruments and disease-specific quality-of-life measures in severe chronic constipation: challenges in practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12955-014-0140-1

Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12955-014-0140-1

Mapping FACT-melanoma quality-of-life scores to EQ-5D health utility weights

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12955-014-0140-1

A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4173059

A comparison of the EQ-5D and SF-6D across seven patient groups

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25214238

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/S12955-014-0140-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214238%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 June 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214238%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

25214238

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214238%20AND%20SRC:MED&resulttype=core&format=json